drugset / Trial / NCT05165732
Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19
RandomizedParallel-groupOpen-labelPrevention
Summary
This is a randomized, Open, control phase Ⅳ clinical trial of inactivated COVID-19 vaccine manufactured by Sinovac Research \& Development Co., Ltd,Beijing institute of Biological Products Co.,Ltd and Wuhan Institute of Biological Products Co.,Ltd.The purpose of this study is to explore booster Immunization of SARS-CoV-2 Inactivated Vaccine from different manufactures in adults aged 18-45 years old Previously Vaccinated with inactivated COVID-19 vaccine
Timeline
- Start
- 2022-12-20
- Primary completion
- 2023-03-20
- Completion
- 2023-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CoronaVac | Vaccine | 600 unknown | — |
| Subject | Inactivated COVID-19 vaccine manufactured by Beijing Institute of Biological Products Co.,Ltd. | Vaccine | 4 ug | — |
| Subject | Inactivated COVID-19 vaccine manufactured by Wuhan Institute of Biological Products Co.,Ltd. | Vaccine | 200 unknown | — |